For the past 10 years, Explicyte has been implementing an automated IHC/IHF workflow, from sample preparation to image analysis & data representation, in the context of translational and clinical studies:
Our digital pathology capacities are now integrated into a comprehensive spatial biology platform dedicated to immuno-oncology.
Since 2015, Explicyte has been providing CRO pathology services for the analysis of preclinical and clinical tumor specimens, treated or not with cancer immunotherapy candidates. Our histopathology platform, assisted by trained pathologists and a dedicated data science team, now totals 150+ validated IHC/IHF markers and 120+ validated panels for immuno-oncology (e.g., T-cell exhaustion, immune contexture, TLS maturity, etc.).
